Member Info for roses

Payment’s (plural) soon

Great info today guys, seems like the stars are aligning for Scancell. Should be another good week for the share price.

Indeed, the more experienced traders will know that the more that a price is tested, the more likely it is to break through it and quite often with great speed.

Indeed, 14p paid

If you do a ‘fill or kill order’ they usually will do it at just above the asking price which quite often then pushes the price up (from my experience)

Thanks vascular, the city analysts (not the ‘advisors’ as one particular negative poster keeps trying to frame it) are advocating for scancell to go it alone for maximum long term value due to the overwhelming results to date and the massive market potential as the new ‘standard of care’

However Scancell have indicated that they prefer partnering with a major and are in advanced and ongoing discussions with several major pharmaceutical companies which will be a near term and medium term excellent result for shareholders although in the long term may not be as financially rewarding but also carries much less risk.

My expectations would be that there will be payments from genmab to scancell in the region of somewhere between 14 to 20 million within the next 6 months

From memory, the previous payments were $5 million each and as we have been told the payments will increase in size at each milestone,

We have also recently been told to expect at least two further payments from them fairly soon.

Genmab always renames their acquired compounds and platforms so it could still be possibly left with a bit of guesswork if it not specifically mentioned tomorrow.

However the wording will possibly give a fairly good assumption to go with?

C11 - can’t argue with that although Scancell have said they are in active discussions with multiple major pharmaceutical companies.

Indeed, very chunky buy ! No wonder they dropped the price to accommodate it.

Poor old crusty, the more vocal he gets, the more his mask is slipping !

Crusty, thankyou for you personal interpretation, which of course you are welcome to provide whether or not is accurate.

Crusty, your agenda is again starting to show through again, its almost like you’re not even trying trying to hide it any more.

There are many options on the options available to the company, they have pretty much told us that they are in talks to partner, however the analysts think there is better shareholder value in going it alone but it looks like more than likely a partnership will be announced soon.

Looks like the market makers are using small volume sells and general market sentiment to justify a drop in the sp in defiance of the obvious buying pressure.

Happy to hold and sit tight as this is going to be a very, very interesting year for Scancell.

Ray, well said !

Couldn’t agree more that we should be speaking to major international pharmaceutical companies (as we are already) instead of government.

However, on the flip side Scancell were the first (to much publicity) to sign up to the new NHS initiative.

So we are in the privileged position of exposure to either outcome.

Emptyend- apologies, I misread and misinterpreted your initial post.

Yes, two delayed trades , one sell for 200k and one buy for 500k

Empty end, I’ve just had a look at the company you were referring to (cyanconnode) and its market cap. Isn’t comparable to scancell, it’s not even a bio company which is definitely not comparable, and I’m struggling to find even one metric which could be used as a comparison ?

However even if the figure you mention is considered, it would still represent an extremely healthy profit for the vast majority.